Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity | Experimental & Molecular Medicine
Biomolecules | Free Full-Text | Emerging Roles for VEGF-D in Human Disease
CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistance - ScienceDirect
Efficacious, safe, and stable inhibition of corneal neovascularization by AAV-vectored anti-VEGF therapeutics - ScienceDirect
Hypoxia-Induced Reactive Oxygen Species Cause Chromosomal Abnormalities in Endothelial Cells in the Tumor Microenvironment | PLOS ONE
Frontiers | The Role of the VEGF Family in Coronary Heart Disease
Elastin-Like Polypeptide: VEGF-B Fusion Protein for Treatment of Preeclampsia | Hypertension
IJMS | Free Full-Text | Endothelial Cells as Tools to Model Tissue Microenvironment in Hypoxia-Dependent Pathologies
Pharmacodynamic and Antitumor Activity of BI 836880, a Dual Vascular Endothelial Growth Factor and Angiopoietin 2 Inhibitor, Alone and Combined with Programmed Cell Death Protein-1 Inhibition | Journal of Pharmacology and Experimental Therapeutics
Counteracting age-related VEGF signaling insufficiency promotes healthy aging and extends life span | Science
![Figure 1 from [The vascular endothelial growth factor (VEGF): a model of gene regulation and a marker of tumour aggressiveness. An obvious therapeutic target?]. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/3369975c581ac8ed2888de7523e6870dbe671b61/2-Figure1-1.png "Figure 1 from [The vascular endothelial growth factor (VEGF): a model of gene regulation and a marker of tumour aggressiveness. An obvious therapeutic target?]. | Semantic Scholar")
Figure 1 from [The vascular endothelial growth factor (VEGF): a model of gene regulation and a marker of tumour aggressiveness. An obvious therapeutic target?]. | Semantic Scholar
Hypoxia Induces VEGF-C Expression in Metastatic Tumor Cells via a HIF-1α-Independent Translation-Mediated Mechanism - ScienceDirect
Frontiers | Tumor Hypoxia Regulates Immune Escape/Invasion: Influence on Angiogenesis and Potential Impact of Hypoxic Biomarkers on Cancer Therapies
Biomedicines | Free Full-Text | Biomarkers as Predictive Factors of Anti- VEGF Response
Hypoxia increases vegf secretion in multiple sources of mesenchymal stem cell - Cytotherapy
The biology of VEGF and its receptors | Nature Medicine
IJMS | Free Full-Text | Hypoxia Pathway Proteins and Their Impact on the Blood Vasculature
Expression of vascular endothelial growth factor, hypoxia inducible factor 1α, and carbonic anhydrase IX in human tumours | Journal of Clinical Pathology
Frontiers | Angiogenesis in Adipose Tissue: The Interplay Between Adipose and Endothelial Cells
Recombinant Human VEGF 165 Protein 293-VE-010: R&D Systems
Association between the CXCL12 → CXCR4 axis and vascular endothelial... | Download Scientific Diagram
Fruquintinib inhibits VEGF/VEGFR2 axis of choroidal endothelial cells and M1-type macrophages to protect against mouse laser-induced choroidal neovascularization | Cell Death & Disease
Markers of vascular damage in COVID-19
Vascular endothelial growth factors (VEGF-A, VEGF-B, VEGF-C,... | Download Scientific Diagram
Human Plasma Levels of VEGF-A, VEGF-C, VEGF-D, their Soluble Receptor - VEGFR-2 and Applicability of these Parameters as Tumor Markers in the Diagnostics of Breast Cancer | SpringerLink
